Skip to main content
. 2018 Jun 4;24(12):1207–1218. doi: 10.1111/cns.12983

Figure 5.

Figure 5

Dihydromyricetin (DHM) decreases Aβ deposition in APP/PS1 mice. A‐C, Plaques were observed in the 2‐ and 4‐week control groups, and the total number of plaques in the 4‐week group was greater than that in the 2‐week group. No plaques were detected in the hippocampus of DHM‐treated groups. Scale bars: 20 μm